Literature DB >> 1774052

The susceptibility of organisms associated with bacterial vaginosis to spermicidal compounds, in vitro.

B M Jones1, L M Willcox.   

Abstract

OBJECTIVES: Bacterial vaginosis (BV) is a prevalent vaginal infection that is now regarded as a risk factor in more serious pelvic and obstetric complications. Spermicides are known to have antimicrobial activity against other sexually transmitted diseases and the aim of this study was to test whether the causative organisms of BV were also susceptible to spermicides, in vitro.
DESIGN: Minimal Inhibitory Concentrations of five spermicidal compounds were determined for the organisms associated with BV, in an agar dilution technique. LOCATION: The Department of Experimental and Clinical Microbiology, University of Sheffield Medical School, UK. SPERMICIDES AND ORGANISMS: Nonoxynol-9, Nonoxynol-11, Docusate sodium, Benzalkonium chloride and Menfegol were tested against 20 strains each of Gardnerella vaginalis, Bacteroides and Mobiluncus organisms, isolated from patients with BV who attended the Department of Genitourinary Medicine, the Royal Hallamshire Hospital, Sheffield. MAIN OUTCOME MEASURES: The susceptibility of BV-associated organisms to spermicidal compounds, in vitro.
RESULTS: G vaginalis, Mobiluncus spp, Bacteroides bivius and Bacteroides disiens were all susceptible to the five spermicides tested, with MICs ranging between less than or equal to 19 and 5000 mg/l (0.0019%-0.5%).
CONCLUSION: The concentrations of spermicides incorporated in contraceptive preparations are usually between 3% and 8%, which are far in excess of the MICs found for BV organisms. Their usage could exert a significant antimicrobial effect and be a useful prophylactic in preventing the infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1774052      PMCID: PMC1194771          DOI: 10.1136/sti.67.6.475

Source DB:  PubMed          Journal:  Genitourin Med        ISSN: 0266-4348


  5 in total

1.  Susceptibility of Haemophilus ducreyi to spermicidal compounds, in vitro.

Authors:  B M Jones; I Geary; M E Lee; B I Duerden
Journal:  Genitourin Med       Date:  1991-06

2.  In vitro evaluations of condoms with and without nonoxynol 9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus.

Authors:  F N Judson; J M Ehret; G F Bodin; M J Levin; C A Rietmeijer
Journal:  Sex Transm Dis       Date:  1989 Apr-Jun       Impact factor: 2.830

Review 3.  Condoms, spermicides, and the transmission of human immunodeficiency virus: a review of the literature.

Authors:  P J Feldblum; J A Fortney
Journal:  Am J Public Health       Date:  1988-01       Impact factor: 9.308

Review 4.  Bacterial vaginosis: etiology, association with preterm labor, diagnosis, and management.

Authors:  J A Swedberg
Journal:  Compr Ther       Date:  1989-08

5.  Haemophilus vaginalis (Corynebacterium vaginale, Gardnerella vaginalis) in a family planning clinic population.

Authors:  H M Bramley; R A Dixon; B M Jones
Journal:  Br J Vener Dis       Date:  1981-02
  5 in total
  2 in total

1.  Lack of evidence for transmission of human immunodeficiency virus through vaginal intercourse.

Authors:  S Brody
Journal:  Arch Sex Behav       Date:  1995-08

2.  In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories.

Authors:  Brigitte E Beer; Gustavo F Doncel; Fred C Krebs; Robin J Shattock; Patricia S Fletcher; Robert W Buckheit; Karen Watson; Charlene S Dezzutti; James E Cummins; Ena Bromley; Nicola Richardson-Harman; Luke A Pallansch; Carol Lackman-Smith; Clay Osterling; Marie Mankowski; Shendra R Miller; Bradley J Catalone; Patricia A Welsh; Mary K Howett; Brian Wigdahl; Jim A Turpin; Patricia Reichelderfer
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.